Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis

OBJECTIVE: Breast cancer survival is lower in low‐ and middle‐income countries (LMICs) partially due to many women being diagnosed with late‐stage disease. The patient interval refers to the time elapsed between the detection of symptoms and the first consultation with a healthcare provider and is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova, Dafina, Garrido, Dunia, Špacírová, Zuzana, Fernández‐Martínez, Nicolás Francisco, Ivanova, Ganka, Rodríguez‐Barranco, Miguel, Pollán, Marina, Barrios‐Rodríguez, Rocío, Sánchez, Maria José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100001/
https://www.ncbi.nlm.nih.gov/pubmed/36345154
http://dx.doi.org/10.1002/pon.6064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100001/
https://www.ncbi.nlm.nih.gov/pubmed/36345154
http://dx.doi.org/10.1002/pon.6064

Ejemplares similares